Florence, Italy, March 28, 2024 – Today, the Hanix group has announced its total acquisition of the shares of EB Neuro S.p.A. EB Neuro S.p.A. is an Italian leading manufacturer of medical devices in the neurological field with equipment for EEG, EMG, TMS and Neuronavigation. It is the first company in the world to have... Read more
Date/Time:Tuesday, March 5th, 2024 - Wednesday, March 6th, 2024 Location:Shenzhen, Guangdong, China In order to expend the distributors' knowledge of TMS and more understanding of YINGCHI TMS device, so as to deal with and solve related problems more effectively, and to consolidate the friendly cooperative relationship with our partners, our company held the 2024 Asia Business Partner... Read more
Date:Monday, Nov. 13 - Thursday, Nov. 16, 2023 CET Location:Düsseldorf, Germany Official Website:https://www.medica-tradefair.com/ YINGCHI Booth:9C54 With over 5,000 exhibitors from 66 countries and more than 81,000 visitors from all over the world, MEDICA in Düsseldorf is one of the largest medical B2B trade fairs in the world. As an old friend, YINGCHI will once again participate in MEDICA 2023.... Read more
In September 2023, YINGCHI M-Ultimate TMS received FDA approval for the treatment of major depressive disorder in adult patients, marking a significant milestone in the company's endeavor to provide safe and effective medical solutions. Moreover, YINGCHI M-Ultimate TMS is not only limited to clinical applications; it is also playing an essential role in advancing clinical... Read more
We are glad to announce that YINGCHI M-Ultimate transcranial magnetic stimulator has already gained FDA approval this September . The M-Ultimate TMS is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode. Depression is a widespread and debilitating mental health condition,... Read more
Visiting time: June 12-16, 2023 With the rapid development of neuromodulation technology, non-invasive neuromodulation technology represented by transcranial magnetic stimulation has been widely used in neuropsychiatric diseases. Among them, deep transcranial magnetic stimulation (DTMS) has significantly improved the magnetic field decay rate, magnetic field penetration depth, and induced electric field area and volume induced in brain tissue.... Read more
